Core business accelerates, while COVID-19 revenue subsides but remains robust
28/04/21 -"Eurofins continued its strong showing with 44.3% organic top-line growth in Q1, building on its robust performance in the second half of last year. The share price came under pressure on the back of ..."
Pages
47
Language
English
Published on
28/04/21
You may also be interested by these reports :
23/10/26
SGS’ Q3 revenues were modestly above expectations, led by a solid contribution from scope and stable organic growth. The beat, however, was largely ...
22/10/26
Rentokil Initial’s Q3’26 organic revenue growth of 3.4% was in line with expectations, with FY26 profit guidance reiterated. Improving contract ...
21/10/26
Eurofins Scientific posted a slight beat on organic growth and revenues, supported by continued strong growth in C&T Product Testing and an ...
21/10/26
Organic revenue growth accelerated beyond expectations in Q3 2026, broadening across geographies. However, the gross margin pressure persisted due to ...